A160e9df-31ca-4711-a98d-457340bd1ca2 - samples

ABSTRACT: To identify the therapeutic targets in a treatment-refractory cancer patient, we performed single-cell RNA sequencing for 3,115 cells from primary bladder cancer (BC159-T#3) and patient-derived xenografts (BC159-T#3-PDX-vehicle and BC159-T#3-PDX-tipifarnib). Matched time-series bulk tumor tissues were also sequenced using whole exome target probe (WES) and whole transcriptome target probe (WTS).

PROVIDER: EGAD00001005978 | EGA |

REPOSITORIES: EGA